Irina Rodriguez, PA
Physician Assistant · Miami, FLNPI 1255632477
Payments from drug & device makers
Across 52 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$320
- Verona Pharma, Inc.$208
- Novo Nordisk$108
- Inspire Medical Systems, Inc.$77
- Mallinckrodt Hospital Products Inc.$47
- Electromed, Inc.$39
- plus $176 from 8 others
What the payments were for
- Food & beverage$974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 16 | $320 |
| Verona Pharma, Inc. | 15 | $208 |
| Novo Nordisk | 6 | $108 |
| Inspire Medical Systems, Inc. | 2 | $77 |
| Mallinckrodt Hospital Products Inc. | 2 | $47 |
| Electromed, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Exeltis, USA Inc. | 2 | $28 |
| Insulet Corporation | 1 | $28 |
| Inogen, Inc. | 1 | $23 |
| BD | 1 | $21 |
| GSK | 1 | $17 |
| Pfizer | 1 | $16 |
| United Therapeutics Corporation | 1 | $14 |
How this compares
$974 in reported general payments places this provider in the 60th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,057 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 93 | $824 |
| Azithromycin | 144 | $413 |
| Dexamethasone | 95 | $402 |
| Celecoxib | 13 | $371 |
| Cephalexin | 49 | $283 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $188 |
| Mupirocin | 15 | $143 |
| Ciprofloxacin Hcl | 36 | $140 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $131 |
| Atorvastatin Calcium | 18 | $122 |
| Amlodipine Besylate | 13 | $97 |
| Doxycycline Hyclate | 16 | $92 |
| Lisinopril | 11 | $80 |
| Losartan Potassium | 11 | $74 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Miami
- Jeanelle KingMiami$424K
- Dallas GreenMiami$202K
- Paula BrezavscekMiami$127K
- Rita QuintanaMiami$110K
- Carol AntequeraMiami$98K
- Ziyad PeerMiami$89K
- Lisa DavisMiami$81K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.